Prodomain of furin promotes phospholipid transfer protein proteasomal degradation in hepatocytes

Yang Yu, Xia Lei, Hui Jiang, Zhiqiang Li, John W.M. Creemers, Ming Zhang, Shucun Qin, Weijun Jin, Xian Cheng Jiang

Research output: Contribution to journalArticle

Abstract

Background--Phospholipid transfer protein (PLTP) is one of the major modulators of lipoprotein metabolism and atherosclerosis development; however, little is known about the regulation of PLTP. The effect of hepatic prodomain of furin (profurin) expression on PLTP processing and function is investigated. Methods and Results--We used adenovirus expressing profurin in mouse liver to evaluate PLTP activity, mass, and plasma lipid levels. We coexpressed PLTP and profurin in human hepatoma cell line cells and studied their interaction. We found profurin expression significantly reduced plasma lipids, plasma PLTP activity, and mass in all tested mouse models, compared with controls. Moreover, the expression of profurin dramatically reduced liver PLTP activity and protein level. We further explored the mechanism using in vivo and ex vivo approaches. We found that profurin can interact with intracellular PLTP and promote its ubiquitination and proteasomal degradation, resulting in less PLTP secretion from the hepatocytes. Furin does not cleave PLTP; instead, it forms a complex with PLTP, likely through its prodomain. Conclusions--Our study reveals that hepatic PLTP protein is targeted for proteasomal degradation by profurin expression, which could be a novel posttranslational mechanism underlying PLTP regulation.

Original languageEnglish (US)
Article numbere008526
JournalJournal of the American Heart Association
Volume7
Issue number9
DOIs
StatePublished - May 1 2018
Externally publishedYes

Fingerprint

Phospholipid Transfer Proteins
Furin
Proteolysis
Hepatocytes
Liver
Lipids
Ubiquitination
Adenoviridae

Keywords

  • Atherosclerosis
  • Furin (PCSK3)
  • Lipids and lipoprotein metabolism
  • Phospholipid transfer protein
  • Profurin
  • Proteasome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Prodomain of furin promotes phospholipid transfer protein proteasomal degradation in hepatocytes. / Yu, Yang; Lei, Xia; Jiang, Hui; Li, Zhiqiang; Creemers, John W.M.; Zhang, Ming; Qin, Shucun; Jin, Weijun; Jiang, Xian Cheng.

In: Journal of the American Heart Association, Vol. 7, No. 9, e008526, 01.05.2018.

Research output: Contribution to journalArticle

Yu, Y, Lei, X, Jiang, H, Li, Z, Creemers, JWM, Zhang, M, Qin, S, Jin, W & Jiang, XC 2018, 'Prodomain of furin promotes phospholipid transfer protein proteasomal degradation in hepatocytes', Journal of the American Heart Association, vol. 7, no. 9, e008526. https://doi.org/10.1161/JAHA.118.008526
Yu, Yang ; Lei, Xia ; Jiang, Hui ; Li, Zhiqiang ; Creemers, John W.M. ; Zhang, Ming ; Qin, Shucun ; Jin, Weijun ; Jiang, Xian Cheng. / Prodomain of furin promotes phospholipid transfer protein proteasomal degradation in hepatocytes. In: Journal of the American Heart Association. 2018 ; Vol. 7, No. 9.
@article{457a75121c294e769a9585c9402b9172,
title = "Prodomain of furin promotes phospholipid transfer protein proteasomal degradation in hepatocytes",
abstract = "Background--Phospholipid transfer protein (PLTP) is one of the major modulators of lipoprotein metabolism and atherosclerosis development; however, little is known about the regulation of PLTP. The effect of hepatic prodomain of furin (profurin) expression on PLTP processing and function is investigated. Methods and Results--We used adenovirus expressing profurin in mouse liver to evaluate PLTP activity, mass, and plasma lipid levels. We coexpressed PLTP and profurin in human hepatoma cell line cells and studied their interaction. We found profurin expression significantly reduced plasma lipids, plasma PLTP activity, and mass in all tested mouse models, compared with controls. Moreover, the expression of profurin dramatically reduced liver PLTP activity and protein level. We further explored the mechanism using in vivo and ex vivo approaches. We found that profurin can interact with intracellular PLTP and promote its ubiquitination and proteasomal degradation, resulting in less PLTP secretion from the hepatocytes. Furin does not cleave PLTP; instead, it forms a complex with PLTP, likely through its prodomain. Conclusions--Our study reveals that hepatic PLTP protein is targeted for proteasomal degradation by profurin expression, which could be a novel posttranslational mechanism underlying PLTP regulation.",
keywords = "Atherosclerosis, Furin (PCSK3), Lipids and lipoprotein metabolism, Phospholipid transfer protein, Profurin, Proteasome",
author = "Yang Yu and Xia Lei and Hui Jiang and Zhiqiang Li and Creemers, {John W.M.} and Ming Zhang and Shucun Qin and Weijun Jin and Jiang, {Xian Cheng}",
year = "2018",
month = "5",
day = "1",
doi = "10.1161/JAHA.118.008526",
language = "English (US)",
volume = "7",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Prodomain of furin promotes phospholipid transfer protein proteasomal degradation in hepatocytes

AU - Yu, Yang

AU - Lei, Xia

AU - Jiang, Hui

AU - Li, Zhiqiang

AU - Creemers, John W.M.

AU - Zhang, Ming

AU - Qin, Shucun

AU - Jin, Weijun

AU - Jiang, Xian Cheng

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Background--Phospholipid transfer protein (PLTP) is one of the major modulators of lipoprotein metabolism and atherosclerosis development; however, little is known about the regulation of PLTP. The effect of hepatic prodomain of furin (profurin) expression on PLTP processing and function is investigated. Methods and Results--We used adenovirus expressing profurin in mouse liver to evaluate PLTP activity, mass, and plasma lipid levels. We coexpressed PLTP and profurin in human hepatoma cell line cells and studied their interaction. We found profurin expression significantly reduced plasma lipids, plasma PLTP activity, and mass in all tested mouse models, compared with controls. Moreover, the expression of profurin dramatically reduced liver PLTP activity and protein level. We further explored the mechanism using in vivo and ex vivo approaches. We found that profurin can interact with intracellular PLTP and promote its ubiquitination and proteasomal degradation, resulting in less PLTP secretion from the hepatocytes. Furin does not cleave PLTP; instead, it forms a complex with PLTP, likely through its prodomain. Conclusions--Our study reveals that hepatic PLTP protein is targeted for proteasomal degradation by profurin expression, which could be a novel posttranslational mechanism underlying PLTP regulation.

AB - Background--Phospholipid transfer protein (PLTP) is one of the major modulators of lipoprotein metabolism and atherosclerosis development; however, little is known about the regulation of PLTP. The effect of hepatic prodomain of furin (profurin) expression on PLTP processing and function is investigated. Methods and Results--We used adenovirus expressing profurin in mouse liver to evaluate PLTP activity, mass, and plasma lipid levels. We coexpressed PLTP and profurin in human hepatoma cell line cells and studied their interaction. We found profurin expression significantly reduced plasma lipids, plasma PLTP activity, and mass in all tested mouse models, compared with controls. Moreover, the expression of profurin dramatically reduced liver PLTP activity and protein level. We further explored the mechanism using in vivo and ex vivo approaches. We found that profurin can interact with intracellular PLTP and promote its ubiquitination and proteasomal degradation, resulting in less PLTP secretion from the hepatocytes. Furin does not cleave PLTP; instead, it forms a complex with PLTP, likely through its prodomain. Conclusions--Our study reveals that hepatic PLTP protein is targeted for proteasomal degradation by profurin expression, which could be a novel posttranslational mechanism underlying PLTP regulation.

KW - Atherosclerosis

KW - Furin (PCSK3)

KW - Lipids and lipoprotein metabolism

KW - Phospholipid transfer protein

KW - Profurin

KW - Proteasome

UR - http://www.scopus.com/inward/record.url?scp=85046413056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046413056&partnerID=8YFLogxK

U2 - 10.1161/JAHA.118.008526

DO - 10.1161/JAHA.118.008526

M3 - Article

C2 - 29680823

AN - SCOPUS:85046413056

VL - 7

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 9

M1 - e008526

ER -